Fisheries and Health Notices




13 AUGUST NEW ZEALAND GAZETTE 2769

on the 11th of September 1997, No. 124, at page 2929 is hereby cancelled.

Dated at Wellington this 10th day of August 1998.

MARK EDWARDS, Policy Manager, Ministry of Fisheries (acting pursuant to delegated authority).

go5758


Health

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Aciclovir 400 mg, 800 mg Tablets Lek Pharmaceutical and Chemical Company, Ljubljana, Slovenia Alpha-Aciclovir
Azathioprine 50 mg Tablet, film coated Douglas Pharmaceuticals Limited, Lincoln, Auckland Azamun
Miconazole 20 mg/mL Spray, topical Stephen Hunter Pty Limited, Ingleburn, New South Wales, Australia Leuko Fungex
Miconazole 2% w/w Powder, topical DFC Thompson Australia Pty Limited, Thornleigh, New South Wales, Australia Leuko Fungex
Miconazole 20 mg/g Cream, topical Stephen Hunter Pty Limited, Ingleburn, New South Wales, Australia Leuko Fungex

Dated this 6th day of August 1998.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go5766


Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Lacidipine 2 mg, 4 mg Tablets, film coated Glaxo Wellcome SA., Aranda de Duero, Spain and Glaxo Wellcome SpA., San Polo di Torrile, Parma, Italy Lacipil
Egg-yolk phospholipid 1.2% w/v, glycerol 2.5% w/v, medium chain triglycerides 5% w/v, soya oil 5% w/v Infusion, solution B Braun Melsungen AG., Melsungen, Germany Lipofundin MCT/LCT 10%
Egg-yolk phospholipid 1.2% w/v, glycerol 2.5% w/v, medium chain triglycerides 10% w/v, soya oil 10% w/v Infusion, solution B Braun Melsungen AG., Melsungen, Germany Lipofundin MCT/LCT 20%
Pravastatin sodium 10 mg, 20 mg Tablets Bristol-Myers Squibb Australia Pty Limited, Noble Park, Victoria, Australia Lipostat
Pink tablet: Ethinyloestradiol 20 µg, levonorgestrel 100 µg Tablets, film coated Ayerst-Wyeth Pharmaceuticals Inc., Barrios Pozo Hondos & Jobos, Guayama, Puerto Rico Loette
Green tablet: Lactose q.s.
Ethinyloestradiol 20 µg, levonorgestrel 100 µg Tablet, film coated Ayerst-Wyeth Pharmaceuticals Inc., Barrios Pozo Hondos & Jobos, Guayama, Puerto Rico Loette 21
Gabapentin 100 mg, 300 mg, 400 mg Capsules, powder filled Goedecke AG., Freiburg, Germany Neurontin
Ranitidine bismuth citrate 400 mg Tablet, film coated Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Pylorid


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1998, No 112


NZLII PDF NZ Gazette 1998, No 112





✨ LLM interpretation of page content

🌾 Cancellation of Fisheries Notice

🌾 Primary Industries & Resources
10 August 1998
Fisheries, Notice Cancellation
  • MARK EDWARDS, Policy Manager, Ministry of Fisheries

🏥 Consent to Distribution of New Medicines

🏥 Health & Social Welfare
6 August 1998
Medicines, Distribution, Consent, New Medicines
  • G. R. BOYD, Chief Advisor, Regulation and Safety

🏥 Consent to Distribution of Changed Medicines

🏥 Health & Social Welfare
Medicines, Distribution, Consent, Changed Medicines